220 related articles for article (PubMed ID: 16484715)
21. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
[TBL] [Abstract][Full Text] [Related]
22. Antioxidants and cancer therapy II: quick reference guide.
Lamson DW; Brignall MS
Altern Med Rev; 2000 Apr; 5(2):152-63. PubMed ID: 10767670
[TBL] [Abstract][Full Text] [Related]
23. Results of a phase II study of high-dose thoracic radiation therapy with concurrent cisplatin and etoposide in limited-stage small-cell lung cancer (NCCTG 95-20-53).
Schild SE; Bonner JA; Hillman S; Kozelsky TF; Vigliotti AP; Marks RS; Graham DL; Soori GS; Kugler JW; Tenglin RC; Wender DB; Adjei A
J Clin Oncol; 2007 Jul; 25(21):3124-9. PubMed ID: 17634491
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature.
Tropé C; Kaern J
J Clin Oncol; 2007 Jul; 25(20):2909-20. PubMed ID: 17617522
[TBL] [Abstract][Full Text] [Related]
25. Invited commentary.
Hoover EL
Ann Thorac Surg; 2007 Apr; 83(4):1278. PubMed ID: 17383326
[No Abstract] [Full Text] [Related]
26. Invited commentary.
Burfeind W
Ann Thorac Surg; 2007 Apr; 83(4):1264. PubMed ID: 17383323
[No Abstract] [Full Text] [Related]
27. Antioxidants and chemotherapy.
Galland L
Altern Ther Health Med; 2007; 13(5):13. PubMed ID: 17900036
[No Abstract] [Full Text] [Related]
28. Chemotherapy for high-risk early-stage endometrial cancer.
Kodama J; Seki N; Hiramatsu Y
Curr Opin Obstet Gynecol; 2007 Feb; 19(1):42-7. PubMed ID: 17218851
[TBL] [Abstract][Full Text] [Related]
29. Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.
Jhawer M; Coit D; Brennan M; Qin LX; Gonen M; Klimstra D; Tang L; Kelsen DP; Shah MA
Am J Clin Oncol; 2009 Aug; 32(4):356-62. PubMed ID: 19381079
[TBL] [Abstract][Full Text] [Related]
30. ACOG Practice Bulletin number 65: management of endometrial cancer.
Hernandez E;
Obstet Gynecol; 2006 Apr; 107(4):952; author reply 952-3. PubMed ID: 16582139
[No Abstract] [Full Text] [Related]
31. Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer.
Salama JK; Stenson KM; List MA; Mell LK; Maccracken E; Cohen EE; Blair E; Vokes EE; Haraf DJ
Arch Otolaryngol Head Neck Surg; 2008 Oct; 134(10):1060-5. PubMed ID: 18936351
[TBL] [Abstract][Full Text] [Related]
32. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
33. An update on randomized clinical trials in localized and locoregional prostate cancer.
Penson DF
Urol Oncol; 2005; 23(4):280-8. PubMed ID: 16018945
[TBL] [Abstract][Full Text] [Related]
34. Trustworthy alteration and improvement in adjuvant treatment of colon cancer.
Harlak A; Soran A
Med Sci Monit; 2006 Mar; 12(3):RA46-52. PubMed ID: 16501433
[TBL] [Abstract][Full Text] [Related]
35. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
36. Adjuvant therapy in patients with resected poor-risk head and neck cancer.
Bernier J; Vermorken JB; Koch WM
J Clin Oncol; 2006 Jun; 24(17):2629-35. PubMed ID: 16763276
[TBL] [Abstract][Full Text] [Related]
37. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.
Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T;
Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609
[TBL] [Abstract][Full Text] [Related]
38. Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response.
Geh JI; Bond SJ; Bentzen SM; Glynne-Jones R
Radiother Oncol; 2006 Mar; 78(3):236-44. PubMed ID: 16545878
[TBL] [Abstract][Full Text] [Related]
39. The multidisciplinary management of rectal cancer.
Meredith KL; Hoffe SE; Shibata D
Surg Clin North Am; 2009 Feb; 89(1):177-215, ix-x. PubMed ID: 19186236
[TBL] [Abstract][Full Text] [Related]
40. Antioxidant supplements during cancer treatments: where do we stand?
Hamilton KK
Clin J Oncol Nurs; 2001; 5(4):181-2. PubMed ID: 12690623
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
